logo-loader
viewIntegumen

Integumen PLC 'the number one thought leader in skin microbiome and AI'

Integumen PLC's (LON:SKIN) Gerry Brandon recaps on 2019 and key highlights including the acquisition of RinoCloud and the deal done with Parity Group.

Brandon adds that they're intending to double the size of its Labskin laboratory in York, currently at 3,162 square feet, which could provide an estimated 10-fold increase on 2019 turnover capacity.

Quick facts: Integumen

Price: 1.465 GBX

AIM:SKIN
Market: AIM
Market Cap: £15.71 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Integumen's Gerry Brandon outlines alliance with South Africa’s Acumen Software

Integumen PLC's (LON:SKIN) Gerry Brandon caught up with Proactive London's Andrew Scott soon after announcing they've formed an alliance with South Africa’s Acumen Software. Acumen's a specialist supplier to municipal and utility customers and the agreement will see Integumen broaden...

2 weeks, 6 days ago

2 min read